Elliott Sherr
Physician · BLUEMARK LLC OFFICE ALLY
Credentials: · · ·
History
- Present
BLUEMARK LLC OFFICE ALLY · UCSF OUTPATIENT PHARMACY AT PARNASSUS
- 1997–2001
Neurology
Research
De novo mutations in epileptic encephalopathies
Nature · 2013 · 1,242 citations
Agenesis of the corpus callosum: genetic, developmental and functional aspects of connectivity
Review · Nature reviews. Neuroscience · 2007 · Last of 7 authors · 613 citations
Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes
Review · Brain · 2014 · 249 citations
24 papers
24 papers
19 papers
- EM
17 papers
16 papers
10 papers
9 papers
8 papers
Grants
- 2022–2027
NSR-GENE (Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy)
National Institute of Neurological Disorders and Stroke · R01
PI · $2.1M · University of California, San Francisco
- 2008–2026
ACC: Callosal Agenesis as a Window into Common Neurodevelopmental Disorders
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $6M · University of California, San Francisco
- 2021–2025
Cellular and Molecular Mechanisms Underlying DDX3X Syndrome
National Institute of Neurological Disorders and Stroke · R01
PI · $2.7M · Duke University
- 2011–2014
4 of 7: Epi4K: Epileptic Encephalopathies Project
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $827.2K · University of California, San Francisco
Clinical trials
- 2011–2014
Simons Variation in Individuals Project, Functional Common Acquisition Protocol
Principal investigator · Completed
University of California, San Francisco
- 2003–2027
Brain Development Research Program
Principal investigator · Recruiting
University of California, San Francisco